Transactions
Showing 1-15 of 950 items
-
US$15m
Lucid Diagnostics
Sole Placement Agent (Registered Direct Offering)
-
US$920m
Waystar
Co-Manager (Follow-On Offering)
-
Exploristics
Exclusive Financial Advisor to Exploristics on its Acquisition by MMS Holdings
-
US$21m
Neuronetics
Sole Bookrunner (Follow-On Offering)
-
Jabil
Exclusive Financial Advisor to Jabil on its Acquisition of Pharmaceutics International
-
Syapse
Financial Advisor to Syapse on its Acquisition by N-Power Medicine
-
US$16m
Markers Therapeutics
Lead Placement Agent (PIPE)
-
Point of Care Network
Financial Advisor to Point of Care Network on its Sale to an Undisclosed Buyer
-
US$92m
Candel Therapeutics
Joint Bookrunner (CMPO)
-
Neuronetics
Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
-
UCB
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
-
Telemos Capital
Exclusive Financial Advisor (Buy side)
-
US$46m
TELA Bio
Joint Bookrunner (Follow-On Offering)
-
US$207m
CeriBell
Co-Manager (IPO)
-
VisiQuate
Financial Advisor to VisiQuate on its Acquisition by Accel-KKR